Cutaneous T cell lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte ™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Soligenix intends to seek guidance from the FDA on how to further advance HyBryte™ towards potential approval PRINCETON, N.J., Feb. 14, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 14, 2023 Category: Pharmaceuticals Source Type: clinical trials

Photopheresis in Early-stage Mycosis Fungoides
Conditions: Cutaneous T Cell Lymphoma; Mycosis Fungoides Interventions: Drug: UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis; Device: THERAKOS® CELLEX photopheresis system Sponsor: Columbia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2023 Category: Research Source Type: clinical trials